Histone deacetylase inhibitors relieve morphine resistance in neuropathic pain after peripheral nerve injury.

[1]  H. Ueda,et al.  HDAC inhibitors restore C‐fibre sensitivity in experimental neuropathic pain model , 2013, British journal of pharmacology.

[2]  T. Nishino,et al.  Valproate attenuates the development of morphine antinociceptive tolerance , 2010, Neuroscience Letters.

[3]  G. Wasner,et al.  Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment , 2010, The Lancet Neurology.

[4]  Lin Ma,et al.  Epigenetic Gene Silencing Underlies C-Fiber Dysfunctions in Neuropathic Pain , 2010, The Journal of Neuroscience.

[5]  K. Omote,et al.  Down-regulation of mu opioid receptor expression within distinct subpopulations of dorsal root ganglion neurons in a murine model of bone cancer pain , 2008, Neuroscience.

[6]  M. Max,et al.  Morphine, nortriptyline and their combination vs. placebo in patients with chronic lumbar root pain , 2007, PAIN.

[7]  I. Wood,et al.  Chromatin crosstalk in development and disease: lessons from REST , 2007, Nature Reviews Genetics.

[8]  H. Loh,et al.  Evidence of the neuron-restrictive silencer factor (NRSF) interaction with Sp3 and its synergic repression to the mu opioid receptor (MOR) gene , 2006, Nucleic acids research.

[9]  I. Takasaki,et al.  Specific down-regulation of spinal mu-opioid receptor and reduced analgesic effects of morphine in mice with postherpetic pain. , 2006, European journal of pharmacology.

[10]  C. Woolf,et al.  Peripheral axonal injury results in reduced μ opioid receptor pre- and post-synaptic action in the spinal cord , 2005, Pain.

[11]  M. Devor,et al.  Efficacy of antiepileptic isomers of valproic acid and valpromide in a rat model of neuropathic pain , 2005, British journal of pharmacology.

[12]  H. Loh,et al.  Neuron-restrictive Silencer Factor (NRSF) Functions as a Repressor in Neuronal Cells to Regulate the μ Opioid Receptor Gene* , 2004, Journal of Biological Chemistry.

[13]  H. Ueda,et al.  Loss of Peripheral Morphine Analgesia Contributes to the Reduced Effectiveness of Systemic Morphine in Neuropathic Pain , 2004, Journal of Pharmacology and Experimental Therapeutics.

[14]  L. Jan,et al.  Contribution of GIRK2-mediated postsynaptic signaling to opiate and α2-adrenergic analgesia and analgesic sex differences , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Ostrovskaya Ru,et al.  GABA-opiates interactions in the activity of analgesics. , 1983 .